Answers are grounded in this paper and cite their sources.
Prospective study investigates anemia's impact on treatment outcomes in tuberculosis patients, indicating clinical implications.
Background: Anemia is frequently observed in patients with pulmonary tuberculosis (PTB). This is one among the few Indian studies to systematically evaluate the prevalence of anemia in PTB and its association with treatment outcome, aiming to provide insights with potential implications for clinical management and prognosis. Materials and Methods: A prospective study was conducted in a Tertiary care hospital, South Tamil Nadu (June 2022–May 2023), including 214 patients with drug-sensitive PTB. Baseline characteristics and hematological parameters, prevalence of anemia were recorded at diagnosis and treatment outcomes were evaluated at the end of 6 months of treatment as per National Tuberculosis Elimination Program guidelines. The recorded data were subjected to statistical analysis. Results: Anemia was present in 74.3% of PTB patients, predominantly moderate in severity. Microcytic hypochromic (53.5%) and normocytic normochromic (25.2%) anemia were the most common. Prevalence was higher in patients with Diabetes, low Body Mass Index, and severe PTB cases requiring hospitalization. The treatment success rate was significantly higher among nonanemic patients than anemic patients (98.1% vs. 87.6%; P < 0.05). Anemic patients exhibited greater mortality risk than nonanemic patients (12.4% vs. 1.9%; P < 0.05), with rates increasing with age. Conclusion: As hemoglobin estimation is inexpensive, routine screening at diagnosis and regular follow-up of anemic patients, especially the older age group, is recommended to improve the treatment outcome.
No takes yet. Share an insight, caveat, or question.
Chandrika et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: